Simultaneous exposure to Escherichia coli heat-labile and heat-stable enterotoxins increases fluid secretion and alters cyclic nucleotide and cytokine production by intestinal epithelial cells

Infection and Immunity

Volumn 82, Issue 12, 2014, Pages 5308-5316

  Read, Lisa T ^a   Hahn, Rachel W ^a   Thompson, Carli C ^a   Bauer, David L ^a   Norton, Elizabeth B ^a   Clements, John D ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC GMP; ESCHERICHIA COLI ENTEROTOXIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; TUMOR NECROSIS FACTOR ALPHA; BACTERIAL TOXIN; CYCLIC NUCLEOTIDE; CYTOKINE; ENTEROTOXIN; ESCHERICHIA COLI PROTEIN; HEAT STABLE TOXIN (E COLI); HEAT-LABILE ENTEROTOXIN, E COLI; WATER;

ADAPTIVE IMMUNITY; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CYCLIC AMP BLOOD LEVEL; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; ENTEROTOXIGENIC ESCHERICHIA COLI; ENZYME ACTIVITY; FEMALE; GASTROINTESTINAL MUCOSA; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; INTESTINAL SECRETION; INTESTINE EPITHELIUM CELL; INTESTINE LOOP; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR BINDING; TOXIN SYNTHESIS; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; DRUG EFFECTS; EPITHELIUM CELL; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ANIMALS; BACTERIAL TOXINS; CELL LINE; CYTOKINES; ENTEROTOXIGENIC ESCHERICHIA COLI; ENTEROTOXINS; EPITHELIAL CELLS; ESCHERICHIA COLI PROTEINS; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; NUCLEOTIDES, CYCLIC; WATER;

EID: 84911398287     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02496-14     Document Type: Article

References (43)

1. Lanata CF, Fischer-Walker CL, Olascoaga AC, Torres CX, Aryee MJ, Black RE, Child Health Epidemiology Reference Group of the World Health Organization, UNICEF. 2013. Global causes of diarrheal disease mortality in children <5 years of age: a systematic review. PLoS One 8:e72788. http://dx.doi.org/10.1371/journal.pone.0072788.
2. Walker CL, Rudan I, Liu L, Nair H, Theodoratou E, Bhutta ZA, O'Brien KL, Campbell H, Black RE. 2013. Global burden of childhood pneumonia and diarrhoea. Lancet 381:1405-1416. http://dx.doi.org/10.1016/S0140-6736(13)60222-6.
3. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, et al. 2012. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095-2128. http://dx.doi.org/10.1016/S0140-6736(12) 61728-0.
4. Qadri F, Saha A, Ahmed T, Al Tarique A, Begum YA, Svennerholm AM. 2007. Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh. Infect. Immun. 75:3961-3968. http://dx.doi.org/10.1128/IAI.00459-07.
5. Isidean SD, Riddle MS, Savarino SJ, Porter CK. 2011. A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression. Vaccine 29:6167-6178. http://dx.doi.org/10.1016/j.vaccine.2011.06.084.
6. Gupta SK, Keck J, Ram PK, Crump JA, Miller MA, Mintz ED. 2008. Part III. Analysis of data gaps pertaining to enterotoxigenic Escherichia coli infections in low and medium human development index countries, 1984-2005. Epidemiol. Infect. 136:721-738. http://dx.doi.org/10.1017/S095026880700934X.
7. Rivera FP, Ochoa TJ, Maves RC, Bernal M, Medina AM, Meza R, Barletta F, Mercado E, Ecker L, Gil AI, Hall ER, Huicho L, Lanata CF. 2010. Genotypic and phenotypic characterization of enterotoxigenic Escherichia coli strains isolated from Peruvian children. J. Clin. Microbiol. 48:3198-3203. http://dx.doi.org/10.1128/JCM.00644-10.
8. Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, Wu Y, Sow SO, Sur D, Breiman RF, Faruque AS, Zaidi AK, Saha D, Alonso PL, Tamboura B, Sanogo D, Onwuchekwa U, Manna B, Ramamurthy T, Kanungo S, Ochieng JB, Omore R, Oundo JO, Hossain A, Das SK, Ahmed S, Qureshi S, Quadri F, Adegbola RA, Antonio M, Hossain MJ, Akinsola A, Mandomando I, Nhampossa T, Acacio S, Biswas K, O'Reilly CE, Mintz ED, Berkeley LY, Muhsen K, Sommerfelt H, Robins-Browne RM, Levine MM. 2013. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 382:209-222. http://dx.doi.org/10.1016/S0140-6736(13)60844-2.
9. Connell TD. 2007. Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heatlabile enterotoxins. Expert Rev. Vaccines 6:821-834. http://dx.doi.org/10.1586/14760584.6.5.821.
10. Clements JD, Finkelstein RA. 1979. Isolation and characterization of homogeneous heat-labile enterotoxins with high specific activity from Escherichia coli cultures. Infect. Immun. 24:760-769.
11. Norton EB, Lawson LB, Freytag LC, Clements JD. 2011. Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G/L211A), as a safe and effective oral adjuvant. Clin. Vaccine Immunol. 18:546-551. http://dx.doi.org/10.1128/CVI.00538-10.
12. Norton EB, Lawson LB, Mahdi Z, Freytag LC, Clements JD. 2012. The A subunit of Escherichia coli heat-labile enterotoxin functions as a mucosal adjuvant and promotes IgG2a, IgA, and Th17 responses to vaccine antigens. Infect. Immun. 80:2426-2435. http://dx.doi.org/10.1128/IAI.00181-12.
13. Moss J, Garrison S, Oppenheimer NJ, Richardson SH. 1979. NADdependent ADP-ribosylation of arginine and proteins by Escherichia coli heat-labile enterotoxin. J. Biol. Chem. 254:6270-6272.
14. Okamoto K, Takahara M. 1990. Synthesis of Escherichia coli heat-stable enterotoxin STp as a pre-pro form and role of the pro sequence in secretion. J. Bacteriol. 172:5260-5265.
15. Yamanaka H, Okamoto K. 1996. Amino acid residues in the pro region of Escherichia coli heat-stable enterotoxin I that affect efficiency of translocation across the inner membrane. Infect. Immun. 64:2700-2708.
16. Weiglmeier PR, Rosch P, Berkner H. 2010. Cure and curse: E. coli heat-stable enterotoxin and its receptor guanylyl cyclase C. Toxins (Basel) 2:2213-2229. http://dx.doi.org/10.3390/toxins2092213.
17. Basu N, Arshad N, Visweswariah SS. 2010. Receptor guanylyl cyclase C (GC-C): regulation and signal transduction. Mol. Cell. Biochem. 334:67-80. http://dx.doi.org/10.1007/s11010-009-0324-x.
18. Urbanski R, Carrithers SL, Waldman SA. 1995. Internalization of E. coli ST mediated by guanylyl cyclase C in T84 human colon carcinoma cells. Biochim. Biophys. Acta 1245:29-36. http://dx.doi.org/10.1016/0304-4165 (95)00068-M.
19. Vaandrager AB, Bot AG, Ruth P, Pfeifer A, Hofmann F, De Jonge HR. 2000. Differential role of cyclic GMP-dependent protein kinase II in ion transport in murine small intestine and colon. Gastroenterology 118:108-114. http://dx.doi.org/10.1016/S0016-5085(00)70419-7.
20. Field M. 2003. Intestinal ion transport and the pathophysiology of diarrhea. J. Clin. Invest. 111:931-943. http://dx.doi.org/10.1172/JCI200318326.
21. Vaandrager AB, Bot AG, De Jonge HR. 1997. Guanosine 3=,5=-cyclic monophosphate-dependent protein kinase II mediates heat-stable enterotoxin-provoked chloride secretion in rat intestine. Gastroenterology 112: 437-443. http://dx.doi.org/10.1053/gast.1997.v112.pm9024297.
22. Forte LR, Thorne PK, Eber SL, Krause WJ, Freeman RH, Francis SH, Corbin JD. 1992. Stimulation of intestinal Cl-transport by heat-stable enterotoxin: activation of cAMP-dependent protein kinase by cGMP. Am. J. Physiol. 263:C607-C615.
23. Glenn GM, Flyer DC, Ellingsworth LR, Frech SA, Frerichs DM, Seid RC, Yu J. 2007. Transcutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patch. Expert Rev. Vaccines 6:809-819. http://dx.doi.org/10.1586/14760584.6.5.809.
24. Summerton NA, Welch RW, Bondoc L, Yang HH, Pleune B, Ramachandran N, Harris AM, Bland D, Jackson WJ, Park S, Clements JD, Nabors GS. 2010. Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin. Vaccine 28:1404-1411. http://dx.doi.org/10.1016/j.vaccine.2009.10.147.
25. Alderete JF, Robertson DC. 1978. Purification and chemical characterization of the heat-stable enterotoxin produced by porcine strains of enterotoxigenic Escherichia coli. Infect. Immun. 19:1021-1030.
26. Cheng E, Cardenas-Freytag L, Clements JD. 1999. The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT). Vaccine 18:38-49. http://dx.doi.org/10.1016/S0264-410X(99)00168-1.
27. Liu S, Veilleux A, Zhang L, Young A, Kwok E, Laliberte F, Chung C, Tota MR, Dube D, Friesen RW, Huang Z. 2005. Dynamic activation of cystic fibrosis transmembrane conductance regulator by type 3 and type 4D phosphodiesterase inhibitors. J. Pharmacol. Exp. Ther. 314:846-854. http://dx.doi.org/10.1124/jpet.105.083519.
28. O'Grady SM, Jiang X, Maniak PJ, Birmachu W, Scribner LR, Bulbulian B, Gullikson GW. 2002. Cyclic AMP-dependent Cl secretion is regulated by multiple phosphodiesterase subtypes in human colonic epithelial cells. J. Membr. Biol. 185:137-144. http://dx.doi.org/10.1007/s00232-001-0120-3.
29. Blount MA, Beasley A, Zoraghi R, Sekhar KR, Bessay EP, Francis SH, Corbin JD. 2004. Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation. Mol. Pharmacol. 66:144-152. http://dx.doi.org/10.1124/mol.66.1.144.
30. Thiagarajah JR, Broadbent T, Hsieh E, Verkman AS. 2004. Prevention of toxin-induced intestinal ion and fluid secretion by a small-molecule CFTR inhibitor. Gastroenterology 126:511-519. http://dx.doi.org/10.1053/j.gastro.2003.11.005.
31. Li LS, Zheng LF, Xu JD, Ji T, Guo H, Li XF, Li Y, Zhang Y, Zhu JX. 2011. Entacapone promotes cAMP-dependent colonic Cl(-) secretion in rats. Neurogastroenterol. Motil. 23:657-e277. http://dx.doi.org/10.1111/j.1365-2982.2011.01715.x.
32. Rampe D, Triggle DJ, Brown AM. 1987. Electrophysiologic and biochemical studies on the putative Ca++ channel blocker MDL 12,330A in an endocrine cell. J. Pharmacol. Exp. Ther. 243:402-407.
33. Li K, Guo D, Zhu H, Hering-Smith KS, Hamm LL, Ouyang J, Dong Y. 2010. Interleukin-6 stimulates epithelial sodium channels in mouse cortical collecting duct cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 299:R590-R595. http://dx.doi.org/10.1152/ajpregu.00207.2009.
34. Utech M, Bruwer M, Nusrat A. 2006. Tight junctions and cell-cell interactions. Methods Mol. Biol. 341:185-195. http://dx.doi.org/10.1385/1-59745-113-4:185.
35. Soriani M, Bailey L, Hirst TR. 2002. Contribution of the ADPribosylating and receptor-binding properties of cholera-like enterotoxins in modulating cytokine secretion by human intestinal epithelial cells. Microbiology 148(Pt 3):667-676.
36. Banks MR, Golder M, Farthing MJ, Burleigh DE. 2004. Intracellular potentiation between two second messenger systems may contribute to cholera toxin induced intestinal secretion in humans. Gut 53:50-57. http://dx.doi.org/10.1136/gut.53.1.50.
37. Lencer WI, Delp C, Neutra MR, Madara JL. 1992. Mechanism of cholera toxin action on a polarized human intestinal epithelial cell line: role of vesicular traffic. J. Cell Biol. 117:1197-1209. http://dx.doi.org/10.1083/jcb.117.6.1197.
38. Dharmsathaphorn K, Madara JL. 1990. Established intestinal cell lines as model systems for electrolyte transport studies. Methods Enzymol. 192: 354-389. http://dx.doi.org/10.1016/0076-6879(90)92082-O.
39. Donato RP, El-Merhibi A, Gundsambuu B, Mak KY, Formosa ER, Wang X, Abbott CA, Powell BC. 2011. Studying permeability in a commonly used epithelial cell line: T84 intestinal epithelial cells. Methods Mol. Biol. 763:115-137. http://dx.doi.org/10.1007/978-1-61779-191-8_8.
40. Toriano R, Kierbel A, Ramirez MA, Malnic G, Parisi M. 2001. Spontaneous water secretion in T84 cells: effects of STa enterotoxin, bumetanide, VIP, forskolin, and A-23187. Am. J. Physiol. Gastrointest. Liver Physiol. 281:G816-G822.
41. Waldman SA, Barber M, Pearlman J, Park J, George R, Parkinson SJ. 1998. Heterogeneity of guanylyl cyclase C expressed by human colorectal cancer cell lines in vitro. Cancer Epidemiol. Biomarkers Prev. 7:505-514.
42. Greenberg DE, Jiang ZD, Steffen R, Verenker MP, DuPont HL. 2002. Markers of inflammation in bacterial diarrhea among travelers, with a focus on enteroaggregative Escherichia coli pathogenicity. J. Infect. Dis. 185:944-949. http://dx.doi.org/10.1086/339617.
43. Loos M, Hellemans A, Cox E. 2013. Optimization of a small intestinal segment perfusion model for heat-stable enterotoxin A induced secretion in pigs. Vet. Immunol. Immunopathol. 152:82-86. http://dx.doi.org/10.1016/j.vetimm.2012.09.014.